Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	9 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Cash Flows from Operating Activities
Net earnings (loss)	$ (81,224)	$ 191,123
Adjustments to reconcile net earnings to net cash provided by operating activities:
Depreciation	197,469	153,714
Amortization	280,667	59,820
Share-based compensation expense	123,674	57,424
Amortization of discount on convertible debt and debt issuance costs	13,690	12,159
Unrealized losses (gains) on foreign currency remeasurements and transactions	(945)	(912)
Gain from equity investments	(435)	(1,641)
Deferred income taxes	(121,277)	(8,917)
Loss on debt extinguishment	6,835	0
Increase (decrease) in cash from changes in (net of effect of acquisitions):
Accounts receivable	50,887	3,764
Inventories	75,096	(184,073)
Accounts payable	(78,985)	27,056
Contract liabilities	13,177	24,473
Income taxes	18,478	19,957
Accrued compensation and benefits	(54,893)	(40,030)
Other operating net assets (liabilities)	10,279	(37,910)
Net cash provided by operating activities	452,493	276,007
Cash Flows from Investing Activities
Additions to property, plant & equipment	(342,999)	(195,991)
Purchases of businesses, net of cash acquired	(5,488,556)	0
Other investing activities	(2,261)	(5,750)
Net cash used in investing activities	(5,833,816)	(201,741)
Cash Flows from Financing Activities
Proceeds from borrowings of Revolving Credit Facility	65,000	0
Proceeds from issuance of Series B Preferred Shares	1,400,000	0
Proceeds from issuance of Senior Notes	0	990,000
Payments on Finisar Notes	0	(14,888)
Payments on borrowings under Revolving Credit Facility	(65,000)	0
Payments on convertible notes	(3,561)	0
Debt issuance costs	(126,516)	(10,197)
Equity issuance costs	(42,000)	0
Proceeds from exercises of stock options and purchases of stock under employee stock purchase plan	21,509	17,177
Payments in satisfaction of employees' minimum tax obligations	(51,836)	(14,948)
Payment of dividends	(20,700)	(27,608)
Other financing activities	(866)	(1,715)
Net cash provided by financing activities	3,682,005	891,283
Effect of exchange rate changes on cash, cash equivalents, and restricted cash	22,532	42,874
Net increase (decrease) in cash, cash equivalents, and restricted cash	(1,676,786)	1,008,423
Cash, Cash Equivalents, and Restricted Cash at Beginning of Period	2,582,371	1,591,892
Cash, Cash Equivalents, and Restricted Cash at End of Period	905,585	2,600,315
Cash paid for interest	190,672	24,158
Cash paid for income taxes	63,485	34,757
Additions to property, plant & equipment included in accounts payable	45,425	71,477
Reconciliation of Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents
Restricted cash	21,000
Cash, cash equivalents, and restricted cash	901,028	2,600,315
Restricted cash, non-current	4,557	0
Total cash, cash equivalents, and restricted cash shown in the Condensed Consolidated Statements of Cash Flows	905,585	2,600,315
Term A Loan
Cash Flows from Financing Activities
Proceeds from borrowing of Term Facility	850,000	0
Payments on existing debt	(1,144,025)	(46,538)
Term B Loan
Cash Flows from Financing Activities
Proceeds from borrowing of Term Facility	$ 2,800,000	$ 0